CervoMed Inc. Repayments of Convertible Debt
CervoMed Inc. (CRVO) reported Repayments of Convertible Debt of $550.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-17.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2020-03-17
- CervoMed Inc. repayments of convertible debt for the quarter ending 2018-12-31 was $0.00.
- CervoMed Inc. repayments of convertible debt for the quarter ending 2018-09-30 was $0.00.
- CervoMed Inc. repayments of convertible debt for the quarter ending 2017-12-31 was $0.00.
- CervoMed Inc. repayments of convertible debt for fiscal 2018 was $550.00K, a 70.74% decline from fiscal 2017.
- CervoMed Inc. repayments of convertible debt for fiscal 2017 was $1.88M.
| Period end | Repayments of Convertible Debt 3 month | Repayments of Convertible Debt 6 month | Repayments of Convertible Debt 9 month | Repayments of Convertible Debt 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $0.00 derived: sum of 2 quarters · filed 2020-03-17 | $550.00K 10-K · filed 2020-03-17 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $550.00K 10-Q · filed 2019-11-08 | ||
| 2018-06-30 | $550.00K 10-Q · filed 2019-08-08 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-19 | $1.88M 10-K · filed 2019-03-19 | ||
| 2017-09-30 | $1.88M 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |